Abivax (ABVX) Financial Statements

Values in USD · ADR · Reports in EUR

ABVX Financial Data

EBITDA$-248.56M

Revenue (TTM)$5.29M

Gross Profit (TTM)$5.29M

Gross Margin—

Operating Margin-5384.14%

ROE-72.96%

ROA-56.84%

Debt/Equity0.07

Current Ratio8.75

FCF$-189.73M

FCF Yield-2.17%

Piotroski F-Score—

Rev/Share (TTM)$0.07

50-Day MA$117.40

200-Day MA$107.56

Shares Outstanding0.07B

ABVX Computed Insights

FCF$-189.73M

FCF Growth Rate—

EPS Growth (CAGR)—

WACC10.00%

Income Statement

Balance Sheet

Cash Flow Statement

ABVX Financial Statements & Data

Abivax (ABVX) financial data including income statement, balance sheet, and cash flow statement. This page provides a comprehensive view of Abivax's financial performance and position as a Healthcare company.

Trailing twelve-month (TTM) revenue is $5.29M. Gross profit (TTM) is $5.29M. EBITDA is $-248.56M. Earnings per share (EPS) is $-5.68. The P/E ratio is -22.42. Market capitalization is $8.75B.

Free cash flow (FCF) is $-189.73M. Weighted average cost of capital (WACC) is 10.00%.

Historical revenue data covers 5 years from FY21 to FY25. Net income history spans 5 years. Free cash flow and capital expenditure data spans 5 years. GoodMoat displays interactive charts for revenue, net income, FCF vs CAPEX, and cash-to-debt ratios to help investors identify financial trends.

Use Abivax's financial data to assess the company's earnings quality, balance sheet health, and cash generation. Compare key metrics across periods to identify trends before making investment decisions with GoodMoat's valuation tools.